Bladder and urethral cancer
Conditions
Interventions
None listed
Sponsors
Nagasaki University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who underwent TURBT or cystoscopic biopsy for bladder or urethral cancer between 01/01/2023 and 31/12/2024
Exclusion criteria
Exclusion criteria: 1.In the case of the same patient undergoing multiple transurethral bladder surgeries with PDD during the research period, from the second time onwards 2.In the case of the same patient undergoing multiple transurethral bladder surgeries without PDD during the research period, from the second time onwards
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence or absence of intraoperative hypotension (defined as systolic blood pressure of less than 80 mmHg or use of vasopressor agents) | — |
Secondary
| Measure | Time frame |
|---|---|
| Presence or absence of post-operative hypotension (defined as cases where hypotension persisted after the operation and it was necessary to continue infusion in the operating theatre, cases where the first systolic blood pressure after returning to the ward was less than 80 mmHg, or cases where continuous vasopressor administration was required after the operation) | — |
Countries
Japan
Contacts
Public ContactMadoka Makino
Nagasaki University Hospital Department of Anesthesiology
Outcome results
None listed